Literature DB >> 21030305

Development and homeostasis of 'resident' myeloid cells: the case of the Langerhans cell.

Laurent Chorro1, Frédéric Geissmann.   

Abstract

Langerhans cells (LCs) are myeloid cells of the epidermis, featured in immunology textbooks as bone marrow-derived antigen-presenting dendritic cells (DCs). A new picture of LC origin, homeostasis and function has emerged, however, after genetic labelling and conditional cell ablation models in mice. LC precursors are recruited into the fetal epidermis, where they differentiate and proliferate in situ. In adults, LCs proliferate at steady state, and during inflammation, in response to signals from neighbouring cells. Here we review the experimental evidence that support either extra-embryonic yolk sac (YS) macrophages or hematopoietic stem cells (HSCs) as the origin of LCs. Beyond LC biology, we propose that YS and HSCs can contribute to the development of distinct subsets of macrophages and DCs.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21030305     DOI: 10.1016/j.it.2010.09.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  25 in total

1.  Casting new light on the TCR.

Authors:  Adrian Hayday; Robert Tigelaar
Journal:  Nat Immunol       Date:  2012-02-16       Impact factor: 25.606

2.  A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury.

Authors:  Ivana R Ferrer; Heather C West; Stephen Henderson; Dmitry S Ushakov; Pedro Santos E Sousa; Jessica Strid; Ronjon Chakraverty; Andrew J Yates; Clare L Bennett
Journal:  Sci Immunol       Date:  2019-08-23

3.  Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses.

Authors:  Botond Z Igyártó; Krystal Haley; Daniela Ortner; Aleh Bobr; Maryam Gerami-Nejad; Brian T Edelson; Sandra M Zurawski; Bernard Malissen; Gerard Zurawski; Judith Berman; Daniel H Kaplan
Journal:  Immunity       Date:  2011-07-21       Impact factor: 31.745

4.  Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility.

Authors:  Hsiao-Wen Su; Nathan J Lanning; David L Morris; Lawrence S Argetsinger; Carey N Lumeng; Christin Carter-Su
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

5.  Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants.

Authors:  Deena Gibbons; Paul Fleming; Alex Virasami; Marie-Laure Michel; Neil J Sebire; Kate Costeloe; Robert Carr; Nigel Klein; Adrian Hayday
Journal:  Nat Med       Date:  2014-09-21       Impact factor: 53.440

Review 6.  Macrophages and CSF-1: implications for development and beyond.

Authors:  Christina V Jones; Sharon D Ricardo
Journal:  Organogenesis       Date:  2013-07-29       Impact factor: 2.500

7.  Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation.

Authors:  Marta E Polak; Stephen M Thirdborough; Chuin Y Ung; Tim Elliott; Eugene Healy; Tom C Freeman; Michael R Ardern-Jones
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

Review 8.  Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions.

Authors:  Prakash Saha; Julia Humphries; Bijan Modarai; Katherine Mattock; Matthew Waltham; Colin E Evans; Anwar Ahmad; Ashish S Patel; Sobath Premaratne; Oliver T A Lyons; Alberto Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

Review 9.  Tissue-resident macrophages.

Authors:  Luke C Davies; Stephen J Jenkins; Judith E Allen; Philip R Taylor
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

10.  Fetal human keratinocytes produce large amounts of antimicrobial peptides: involvement of histone-methylation processes.

Authors:  Maria Gschwandtner; Shaomin Zhong; Antonia Tschachler; Veronika Mlitz; Susanne Karner; Adelheid Elbe-Bürger; Michael Mildner
Journal:  J Invest Dermatol       Date:  2014-04-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.